Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease

Azathioprine is widely used for the treatment of Crohn’s disease (CD). Few cases from Western countries have reported idiopathic non-cirrhotic portal hypertension (NCPH) related to thiopurine therapy in patients with inflammatory bowel disease. Idiopathic NCPH is a rare hepatic condition with intrah...

Full description

Bibliographic Details
Main Authors: Jong Won Seo, Eun Soo Kim, Man-Hoon Han, Young Oh Kweon
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2021-04-01
Series:Intestinal Research
Subjects:
Online Access:http://www.irjournal.org/upload/pdf/ir-2020-00016.pdf
_version_ 1818720668536012800
author Jong Won Seo
Eun Soo Kim
Man-Hoon Han
Young Oh Kweon
author_facet Jong Won Seo
Eun Soo Kim
Man-Hoon Han
Young Oh Kweon
author_sort Jong Won Seo
collection DOAJ
description Azathioprine is widely used for the treatment of Crohn’s disease (CD). Few cases from Western countries have reported idiopathic non-cirrhotic portal hypertension (NCPH) related to thiopurine therapy in patients with inflammatory bowel disease. Idiopathic NCPH is a rare hepatic condition with intrahepatic portal hypertension but no evidence of cirrhosis or chronic liver disease. Patients with idiopathic NCPH present with symptoms of portal hypertension such as thrombocytopenia, splenomegaly and esophageal varices. We report a case of idiopathic NCPH in a 51-year-old male patient with CD who had been taking azathioprine for 5 years. He was admitted due to esophageal variceal bleeding along with splenomegaly and thrombocytopenia. Evaluation of cirrhosis or chronic liver disease showed normal-range results as estimated by FibroScan evaluation, laboratory examination for autoimmune hepatitis or viral hepatitis, and liver biopsy. This case may suggest the need for careful monitoring for manifestations of portal hypertension in Asian patients with inflammatory bowel disease receiving thiopurine treatment.
first_indexed 2024-12-17T20:26:30Z
format Article
id doaj.art-e2c967d4573a4019b197c57ba95cf6a6
institution Directory Open Access Journal
issn 1598-9100
2288-1956
language English
last_indexed 2024-12-17T20:26:30Z
publishDate 2021-04-01
publisher Korean Association for the Study of Intestinal Diseases
record_format Article
series Intestinal Research
spelling doaj.art-e2c967d4573a4019b197c57ba95cf6a62022-12-21T21:33:46ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562021-04-0119224725110.5217/ir.2020.00016852Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s diseaseJong Won Seo0Eun Soo Kim1Man-Hoon Han2Young Oh Kweon3 Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Korea Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, KoreaAzathioprine is widely used for the treatment of Crohn’s disease (CD). Few cases from Western countries have reported idiopathic non-cirrhotic portal hypertension (NCPH) related to thiopurine therapy in patients with inflammatory bowel disease. Idiopathic NCPH is a rare hepatic condition with intrahepatic portal hypertension but no evidence of cirrhosis or chronic liver disease. Patients with idiopathic NCPH present with symptoms of portal hypertension such as thrombocytopenia, splenomegaly and esophageal varices. We report a case of idiopathic NCPH in a 51-year-old male patient with CD who had been taking azathioprine for 5 years. He was admitted due to esophageal variceal bleeding along with splenomegaly and thrombocytopenia. Evaluation of cirrhosis or chronic liver disease showed normal-range results as estimated by FibroScan evaluation, laboratory examination for autoimmune hepatitis or viral hepatitis, and liver biopsy. This case may suggest the need for careful monitoring for manifestations of portal hypertension in Asian patients with inflammatory bowel disease receiving thiopurine treatment.http://www.irjournal.org/upload/pdf/ir-2020-00016.pdfcrohn diseaseazathioprinenon-cirrhotic portal hypertension
spellingShingle Jong Won Seo
Eun Soo Kim
Man-Hoon Han
Young Oh Kweon
Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
Intestinal Research
crohn disease
azathioprine
non-cirrhotic portal hypertension
title Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
title_full Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
title_fullStr Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
title_full_unstemmed Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
title_short Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
title_sort non cirrhotic portal hypertension related to azathioprine therapy in a patient with crohn s disease
topic crohn disease
azathioprine
non-cirrhotic portal hypertension
url http://www.irjournal.org/upload/pdf/ir-2020-00016.pdf
work_keys_str_mv AT jongwonseo noncirrhoticportalhypertensionrelatedtoazathioprinetherapyinapatientwithcrohnsdisease
AT eunsookim noncirrhoticportalhypertensionrelatedtoazathioprinetherapyinapatientwithcrohnsdisease
AT manhoonhan noncirrhoticportalhypertensionrelatedtoazathioprinetherapyinapatientwithcrohnsdisease
AT youngohkweon noncirrhoticportalhypertensionrelatedtoazathioprinetherapyinapatientwithcrohnsdisease